UK Industry Code of Practice: latest Report

4 March 1996

The new UK Code of Practice for the Pharmaceutical Industry took effect on January 1, 1996. How-ever, until March 31, no promotional mat-erial or activity will be regarded in breach of the Code if it fails to comply with its provisions only because of requirements which the 1996 edition newly introduces, says the Prescription Medicines Code of Practice Authority, in the preface to its latest Code of Practice Review.

The Authority also asks that complaints should be made clearly, as it is often difficult to be certain what exactly is being complained about in inter-company complaints. Complaints which consist of a critical essay on a promotional item but never really come to the point as to the allegations being made are difficult to deal with, which means, as a result, that particular aspects may not receive adequate attention, it says.

The complaints dealt with in the current Review concern the following:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight